Satı Özkan Tabakçı

Satı Özkan Tabakçı

Auto-generated profile, based on publicly available information

Satı Özkan Tabakçı

Department of Pediatric Pulmonology, Ankara Bilkent City Hospital, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
GTGökçen Dilşa Tuğcu
Gökçen Dilşa Tuğcu
SPSanem Eryılmaz Polat
Sanem Eryılmaz Polat
SSSule Selin Akyan Soydaş
Sule Selin Akyan Soydaş
EOEce Ocak
Ece Ocak
MGMurat Yasin Gençoğlu
Murat Yasin Gençoğlu
GCGüzin Cinel
Güzin Cinel

12 June 2025 in Pediatric Pulmonology
Verified
Journal Article
Open access
BSBirce SUNMAN
Birce SUNMAN
EYEbru Yalçın
Ebru Yalçın
MEMeltem Akgül Erdal
Meltem Akgül Erdal
VŞVelat Şen
Velat Şen
ABAzer Kilic Baskan
Azer Kilic Baskan
DDDeniz Doğru
Deniz Doğru
Background: Modulators have revolutionized cystic fibrosis (CF) management, but their effects on respiratory pathogens remain unclear. This study evaluated changes in lower respiratory tract pathogen detection after modulator therapy in children with CF, registered in the Cystic Fibrosis Registry of Turkey. Method: This retrospective, multicenter cohort study included children receiving modulator therapy between 2020 and 2022. Chronic respiratory tract colonization rates before and after therapy were compared, along with inhaler treatments, oral steroid, azithromycin use, pulmonary function tests, and hospitalizations for pulmonary exacerbations. The cohort was stratified by age, modulator type, and lung disease severity. Changes in microbiologic data over a 1‐year period were also analyzed for children not receiving modulator therapy. Results: A total of 101 children (mean age 9.95 ± 4.44 years) were included. Following modulator therapy, respiratory cultures of 57 (56.4%) were negative. Among 32 children with chronic Pseudomonas aeruginosa ( P. aeruginosa ) colonization, 14 (44%) showed negative respiratory cultures after receiving modulator therapy ( p = 0.039). Conversion to culture‐negative status was significant for methicillin‐sensitive Staphylococcus aureus (MSSA) ( p = 0.022) and methicillin‐resistant Staphylococcus aureus (MRSA) ( p = 0.034), with ETI therapy yielding the highest conversion rates. Inhaled antibiotic use for chronic respiratory pathogens decreased significantly ( p = 0.039), and spirometry parameters improved ( p < 0.001). Among 1232 children not receiving modulators, 180 (14.6%) had negative respiratory cultures when examined at 1‐year interval. In the same group, intermittent/chronic P. aeruginosa colonization was negative in 58 cases, while 85 developed new growth, following modulator therapy, with positivity rates rising from 16.3% to 18.5% ( p = 0.030). No significant changes in other pathogen detection were observed. Conclusion: Modulators, particularly ETI, reduced respiratory pathogen detection and improved lung function in children with CF.

26 September 2025 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
GTGökçen Dilşa Tuğcu
Gökçen Dilşa Tuğcu
GTGökçen Dilşa Tuğcu
Gökçen Dilşa Tuğcu
SPSanem Eryılmaz Polat
Sanem Eryılmaz Polat
RDRabia Demir
Rabia Demir
MGMurat Yasin Gençoğlu
Murat Yasin Gençoğlu
GCGüzin Cinel
Güzin Cinel

19 June 2024 in Pediatric Pulmonology
Verified
Journal Article
Closed access
SPSanem Eryılmaz Polat
Sanem Eryılmaz Polat
FAFatma Merve Arıkan
Fatma Merve Arıkan
MGMurat Yasin Gençoğlu
Murat Yasin Gençoğlu
ŞAŞule Selin Akyan
Şule Selin Akyan
SUSalih Uytun
Salih Uytun
GCGüzin Cinel
Güzin Cinel

12 January 2026 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SPSanem Eryılmaz Polat
Sanem Eryılmaz Polat
STSatı Özkan Tabakçı
Satı Özkan Tabakçı
IBIşıl Bilgiç
Işıl Bilgiç
ÇYÇelebi Yıldırım
Çelebi Yıldırım
HYHande Yetişgin
Hande Yetişgin
GCGüzin Cinel
Güzin Cinel

12 February 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
AÜAyyüce Ünlü
Ayyüce Ünlü
ŞSŞule Seli̇n Akyan Soydaş
Şule Seli̇n Akyan Soydaş
STSati Özkan Tabakçi
Sati Özkan Tabakçi
IBIşil Bi̇lGi̇ç
Işil Bi̇lGi̇ç
MÇMeltem Kürtül Çakar
Meltem Kürtül Çakar
GCGüzi̇n Ci̇nEl
Güzi̇n Ci̇nEl
Background/aim: Childhood interstitial lung diseases (chILD) constitute a rare and clinically complex group of disorders. This study aimed to characterize the clinical, radiological, and genetic features, as well as the outcomes, of chILD in a Turkish cohort classified according to the chILD-EU framework. Materials and methods: We retrospectively reviewed the medical records of 84 pediatric patients diagnosed with chILD between 2017 and 2024 at a tertiary referral center in Türkiye. Patients were categorized according to the chILD-EU classification. Clinical variables, imaging findings, genetic analyses, pulmonary function test results, and Fan severity scores were systematically assessed. Logistic regression analysis was performed to identify independent predictors of clinical instability. Results: The median age at diagnosis was 6.0 years (IQR: 1.1–12.9). Surfactant dysfunction disorders (A4) and immune- or environmental-related diseases (B2) were the most frequently identified subtypes. Hypoxia was observed in 36 of 84 patients (42.8%) and emerged as the strongest independent predictor of clinical instability (OR: 8.5; 95% CI: 2.2–33.0; p = 0.002). Pathogenic or likely pathogenic variants were identified in 18 of 84 patients (21.4%); among variant-positive cases, ABCA3 was the most frequently affected gene (3 of 18; 16.7%). Chest computed tomography was available in 82 of 84 patients, with ground-glass opacities being the most common finding, observed in 51 of 82 patients (62.2%). A decrease of at least one point in the Fan severity score was observed in 42 of 84 patients (p < 0.001). Mortality was 12 of 84 patients (14.3%) after a median follow-up of 3.2 years (range: 1.2–4). Conclusion: This study presents one of the largest single-center pediatric chILD cohorts reported from Türkiye. It highlights the prognostic relevance of baseline hypoxia and underscores the importance of comprehensive radiological and genetic assessment in the management of chILD.